The progression of Alzheimer’s disease (AD), a leading cause of dementia worldwide, is known for its variability and complexity, challenging the conventional methods of monitoring and predicting ...

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that begins with subtle cognitive changes and advances to severe impairment. Early diagnosis is crucial for effective intervention ...

(a) Disease progression can be classified into three states: the normal stage, pre-disease stage and disease stage, with the pre-disease stage representing a critical threshold just before the onset ...

Chronic kidney disease (CKD) is a complex condition marked by a gradual decline in kidney function, which can ultimately progress to end-stage renal disease (ESRD). Globally, the prevalence of CKD ...

Lupus is a spectrum disease, with some patients experiencing primarily skin involvement and others facing life-threatening systemic complications affecting kidneys, joints, and more. A major challenge ...

Please provide your email address to receive an email when new articles are posted on . Researchers used machine learning to predict glaucoma progression based on ...

New research from the University of St Andrews, the University of Copenhagen and Drexel University has developed AI computational models that predict the degeneration of neural networks in amyotrophic ...

This symposium reviewed the evolving understanding of the molecular pathophysiology and disease heterogeneity across Alzheimer's disease (AD) and Parkinson's disease (PD). Explored current and ...

In this Innovation Spotlight, Gene Mack, the chief executive officer of Gain Therapeutics, discusses the company’s Magellan™ platform, which uss machine learning and structural modeling to identify ...

Digestive symptoms often appear years before tremor in Parkinson’s disease, and growing evidence suggests the gut-brain axis may play a critical role in early disease processes and symptom management.